The treatment of NSCLC has been attempted with standard chemotherapeutic agents like cisplatin, as well as with new drugs such as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.